Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for prevention of postoperative delirium after laparoscopic colorectal surgery in older adults
ChiCTR2100050314Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in postoperative delirium (POD) (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Postoperative delirium. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100050314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050314.